Summary of clinical results

DUCRAY
Kertyol PSO Baume

Tolerance and efficacy of KERTYOL PSO daily balm

Tolerance and efficacy of KERTYOL PSO daily balm used alone in mild to moderate plaque psoriasis, under dermatological control

Population

43 adult subjects with stable mild to moderate plaque psoriasis on the body (PASI < 10 over the past 6 months)

 

Application of KERTYOL PSO daily balm

Application once a day to the entire body for 4 weeks

 

Evaluation criteria

  • Evaluation of average pruritus intensity over the previous 24 hours by the subject (NRS scale)
  • Evaluation of pruritus severity and its impact on quality of life (Chronic Itch Questionnaire Patient Reported Outcome)
  • Scoring of xerosis intensity by the investigators (score from 0 to 4)
  • Skin tolerance under dermatological control

Results

  •  From 8 days, significant decrease in pruritus sensations of –39%
EN-Kertyol PSO Baume · Évolution prurit.png
  • From 8 days, improvement in the quality of Sleep and self-confidence
EN-Kertyol PSO Baume · Évolution trouble du sommeil.png
EN-Kertyol PSO Baume · Évolution confiance en soi.png
  • -47% decrease in xerosis from 8 days 
  • Excellent skin tolerance

 

Conclusion

  • Soothing of pruritus related to psoriasis from the 1st week of application
  • Improvement of patient quality of life in relation to pruritus severity
  • Excellent skin tolerance

More summaries of clinical results

  • Psoriasis
Tolerance and efficacy of KERTYOL PSO shampoo
DUCRAY
Tolerance and efficacy of KERTYOL PSO Rebalancing treatment shampoo used alone in mild to moderate psoriasis of the scalp, under dermatological control